Gait Variability Detects Women in Early Postmenopause With Low Bone Mineral Density
نویسندگان
چکیده
منابع مشابه
Romosozumab in postmenopausal women with low bone mineral density.
BACKGROUND Sclerostin is an osteocyte-derived inhibitor of osteoblast activity. The monoclonal antibody romosozumab binds to sclerostin and increases bone formation. METHODS In a phase 2, multicenter, international, randomized, placebo-controlled, parallel-group, eight-group study, we evaluated the efficacy and safety of romosozumab over a 12-month period in 419 postmenopausal women, 55 to 85...
متن کامل[Factors associated with low bone mineral density among white women].
OBJECTIVE To analyze whether the factors causing low bone mineral density among elderly women are the same as those observed in other age groups. METHODS A cross-sectional study was carried out on the medical records of a random sample of 413 white women seen at an imaging diagnostics service in a city of Southern Brazil, in 2003. Femoral bone mineral densities with adjustment using T-scores ...
متن کاملBone mineral density in women with depression.
BACKGROUND Depression is associated with alterations in behavior and neuroendocrine systems that are risk factors for decreased bone mineral density. This study was undertaken to determine whether women with past or current major depression have demonstrable decreases in bone density. METHODS We measured bone mineral density at the hip, spine, and radius in 24 women with past or current major...
متن کاملLow bone mineral density and fracture burden in postmenopausal women.
BACKGROUND The study objectives were to determine fracture rates in relation to bone mineral density at various central skeletal sites, using the World Health Organization definition for osteoporosis (T-score -2.5 or less), and to contrast fracture patterns among women 50 to 64 years of age with those among women 65 years of age and older. METHODS Historical cohort study with a mean observati...
متن کاملEffect of intravenous zolendronic acid on bone mineral density in post-menopausal women with low bone mineral density.
Background : Menopause is the period during which systemic oestrogen level is reduced. During postmenopausal period, bone remodelling cycle is distorted and is occasionally associated with low bone mass which is the major determinant of bone strength. Zoledronic acid, a third generation bisphosphonates available as an alternative formulation approved for the treatment of postmenopausal women. A...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Physical Therapy
سال: 2009
ISSN: 0031-9023,1538-6724
DOI: 10.2522/ptj.20080401